Advertisement

Ultrasound and PCOS

  • Nikolaos Prapas
  • Artemis Karkanaki
Chapter

Abstract

Polycystic ovary syndrome (PCOS) is a common medical entity affecting up to 10 % of women of reproductive age. Until 2003, when polycystic ovarian morphology was included, the diagnosis of PCOS was based on the presence of clinical or laboratory evidence of hyperandrogenemia and chronic oligo- or anovulation. Despite the name of the syndrome, the polycystic ovarian morphology was not considered pathognomonic for the diagnosis. During the Consensus Workshop in Rotterdam, the sonographic evidence of polycystic morphology was recognized as equal diagnostic criterion of the syndrome and was further defined and simplified into the presence of either 12 or more follicles of 2–9 mm of diameter or an increased ovarian volume of more than 10 cm3. Thereafter, the technical refinement of the ultrasound equipment, the introduction of three-dimensional imaging, the rise of four distinct phenotypes of the syndrome, the connection of PCOS with metabolic disturbances and infertility implications, the results of well-designed studies, and, finally, the inherent trend for improvement of the clinical practice brought to the surface the necessity to fine-tune the definition of polycystic ovarian morphology. In this direction, there have been proposals to modify the threshold in the number of the antral follicles and the ovarian volume, according to the results of subsequent studies. Other researchers supported the role of three-dimensional screening as it provides better spatial perception and, consequently, more accurate follicle count. Additionally, 3D ultrasound offers the possibility to assess the degree of stromal echogenicity and vascularization that could be important features of the syndrome in combination with the peripheral distribution of the follicles. The substitution of ultrasound examination by anti-Mullerian hormone (AMH) measurement has also been proposed as a more precise method of evaluation of the ovarian function and reserve, especially in cases of controlled ovarian stimulation. All these controversies have been proven creative and will lead to a promising future of the ultrasound imaging in the diagnosis, definition, and treatment of the clinical manifestations of PCOS as acne, anovulation, and most importantly infertility.

Keywords

Granulosa Cell Pulsatility Index Antral Follicle Antral Follicle Count Control Ovarian Stimulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Franks S. Polycystic ovary syndrome. N Engl J Med. 1995;333:853–61. Erratum in: N Engl J Med. 1995;333:1435.PubMedGoogle Scholar
  2. 2.
    Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab. 1999;84:4006–11.PubMedGoogle Scholar
  3. 3.
    Zawadzki JA, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377–84.Google Scholar
  4. 4.
    The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.Google Scholar
  5. 5.
    The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004;81:19–25.Google Scholar
  6. 6.
    Karkanaki A, Piouka A, Katsikis I, Farmakiotis D, Macut D, Panidis D. Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients. Fertil Steril. 2009;92:2078–81.PubMedGoogle Scholar
  7. 7.
    Diamanti-Kandarakis E, Panidis D. Unraveling the phenotyping map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf). 2007;67:735–42.Google Scholar
  8. 8.
    Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women. Lancet. 1988;1:870–2.PubMedGoogle Scholar
  9. 9.
    Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf). 1992;37:127–34.Google Scholar
  10. 10.
    Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF, Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.PubMedGoogle Scholar
  11. 11.
    Christensen JT, Boldsoen J, Westergaard JG. Ovarian volume in gynecologically healthy women using contraception or using IUD. Acta Obstet Gynecol Scand. 1997;76:784–9.PubMedGoogle Scholar
  12. 12.
    Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod. 2003;9:505–14.Google Scholar
  13. 13.
    Zaidi J, Jurkovic D, Campbell S, Pitroff R, McGregor A, Tan SL. Description of circadian rhythm in uterine artery blood flow indices during the peri-ovulatory period. Hum Reprod. 1995;10:1642–6.PubMedGoogle Scholar
  14. 14.
    Zaidi J, Tan SL, Pitroff R, Campbell S, Collins W. Blood flow changes in the intra-ovarian arteries during the peri-ovulatory period-relationship to the time of day. Ultrasound Obstet Gynecol. 1996;7:135–40.PubMedGoogle Scholar
  15. 15.
    Adams J, Franks S, Polson DW, Mason HD, Abdulwahid N, Tucker M, Morris DV, Price J, Jacobs HS. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet. 1985;2:1375–9.PubMedGoogle Scholar
  16. 16.
    Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod. 2003;18:598–603.PubMedGoogle Scholar
  17. 17.
    Jonard S, Dewailly D, Pigny P, Robert Y, Decanter C. What are the determinants of the antral follicle number at ovarian ultrasonography (U/S) in PCOS? ESHRE Congress, Madrid, 29 June to 3 July 2003, oral communication, 0–119. Hum Reprod. 2003;18 Suppl 1:42.Google Scholar
  18. 18.
    Raine-Fenning N. What’s in a number? The polycystic ovary revisited. Hum Reprod. 2011;11:3118–22.Google Scholar
  19. 19.
    Balen AH, Dunger D. Pubertal maturation of the internal genitalia. Ultrasound Obstet Gynecol. 1995;6:164–5.PubMedGoogle Scholar
  20. 20.
    Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, Murphy R, Addauan-Andersen C, McConnell D, Pera RR, Cedars MI. The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab. 2010;95:4965–72.PubMedGoogle Scholar
  21. 21.
    Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF, Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456–88.PubMedGoogle Scholar
  22. 22.
    Adams JM, Taylor AE, Crowley Jr WF, Hall JE. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome. J Clin Endocrinol Metab. 2004;89:4343–50.PubMedGoogle Scholar
  23. 23.
    Kousta E, Cela E, Lawrence N, Penny A, Millauer B, White D, et al. The prevalence of polycystic ovaries in women with a history of gestational diabetes. Clin Endocrinol (Oxf). 2000;53:501–7.Google Scholar
  24. 24.
    Koivunen R, Laatikainen T, Tomas C, Huhtaniemi I, Tapanainen J, Martikainen H. The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynecol Scand. 1999;78:137–41.PubMedGoogle Scholar
  25. 25.
    Swanton A, Storey L, McVeigh E, Child T. IVF outcome in women with PCOS, PCO and normal ovarian morphology. Eur J Obstet Gynecol Reprod Biol. 2010;149:68–71.PubMedGoogle Scholar
  26. 26.
    Esinler I, Bayar U, Bozdag G, Yarali H. Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril. 2005;84:932–7.PubMedGoogle Scholar
  27. 27.
    McDougall MJ, Tan SL, Jacobs HS. IVF and the ovarian hyperstimulation syndrome. Hum Reprod. 1992;5:597–600.Google Scholar
  28. 28.
    Sahu B, Ozturk O, Ranierri M, Serhal P. Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet. 2008;277:239–44.PubMedGoogle Scholar
  29. 29.
    Elting MW, Kwee J, Schats R, Rekers-Mombarg LT, Schoemaker J. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. J Clin Endocrinol Metab. 2001;86:1589–95.PubMedGoogle Scholar
  30. 30.
    Catteau-Jonard S, Bancquart J, Poncelet E, Lefebvre-Maunoury C, Robin G, Dewailly D. Polycystic ovaries at ultrasound: normal variant or silent Polycystic Ovary Syndrome? Ultrasound Obstet Gynecol. 2012;40(2):223–9. doi: 10.1002/uog.11202.PubMedGoogle Scholar
  31. 31.
    Eldar-Geva T, Margalioth EJ, Gal M, Ben-Chetrit A, Algur N, Zylber-Haran E, Brooks B, Huerta M, Spitz IM. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod. 2005;20:1814–9.PubMedGoogle Scholar
  32. 32.
    Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. 2008;89:84–91.PubMedGoogle Scholar
  33. 33.
    Son WY, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Reprod Update. 2010;16:675–89.PubMedGoogle Scholar
  34. 34.
    Nardo LG, Gelbaya TA. Evidence-based approach for the use of ultrasound in the management of polycystic ovary syndrome. Minerva Ginecol. 2008;60:83–9.PubMedGoogle Scholar
  35. 35.
    Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718.PubMedGoogle Scholar
  36. 36.
    Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER. Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril. 1999;72:845–51.PubMedGoogle Scholar
  37. 37.
    Kline J, Kinney A, Kelly A, Reuss ML, Levin B. Predictors of antral follicle count during the reproductive years. Hum Reprod. 2005;20:2179–89.PubMedGoogle Scholar
  38. 38.
    Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimüllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705–14.PubMedGoogle Scholar
  39. 39.
    Broekmans FJM, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril. 2010;94:1044–51.PubMedGoogle Scholar
  40. 40.
    Craig J, Orisaka M, Wang H, Orisaka S, Thompson W, Zhu C, et al. Gonadotropin and intra-ovarian signals regulating follicle development and atresia: the delicate balance between life and death. Front Biosci. 2007;12:3628–39.PubMedGoogle Scholar
  41. 41.
    Charleston JS, Hansen KR, Thyer AC, Charleston LB, Gougeon A, Siebert JR, et al. Estimating human ovarian non-growing follicle number: the application of modern stereology techniques to an old problem. Hum Reprod. 2007;22:2103–10.PubMedGoogle Scholar
  42. 42.
    Gougeon A. Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. Ann Endocrinol (Paris). 2010;71:132–43.Google Scholar
  43. 43.
    Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–55.PubMedGoogle Scholar
  44. 44.
    Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause. 2004;11:607–14.PubMedGoogle Scholar
  45. 45.
    van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065–71.PubMedGoogle Scholar
  46. 46.
    Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas. 1998;30:137–42.PubMedGoogle Scholar
  47. 47.
    Deb S, Campbell BK, Clewes JS, Raine-Fenning NJ. Quantitative analysis of antral follicle number and size: a comparison of two-dimension and automated three-dimension ultrasound techniques. Ultrasound Obstet Gynecol. 2010;35:354–60.PubMedGoogle Scholar
  48. 48.
    Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet. 2003;362:1017–21.PubMedGoogle Scholar
  49. 49.
    Dewailly D, Catteau-Jonard S, Reyss AC, Maunoury-Lefebvre C, Poncelet E, Pigny P. The excess in 2–5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome. Hum Reprod. 2007;22:1562–6.PubMedGoogle Scholar
  50. 50.
    Raine-Fenning N, Jayaprakasan K, Clewes J. Automated follicle tracking facilitates standardization and may improve work flow. Ultrasound Obstet Gynecol. 2007;30:1015–8.PubMedGoogle Scholar
  51. 51.
    Raine-Fenning N, Jayaprakasan K, Clewes J, Joergner I, Bonaki SD, Chamberlain S, Devlin L, Priddle H, Johnson I. SonoAVC: a novel method of automatic volume calculation. Ultrasound Obstet Gynecol. 2008;31:691–6.PubMedGoogle Scholar
  52. 52.
    Wittmaack FM, Kreger DO, Blasco L, Tureck RW, Mastroianni Jr L, Lessey BA. Effect of follicular size on oocyte retrieval, fertilization, cleavage, and embryo quality in in vitro fertilization cycles: a 6-year data collection. Fertil Steril. 1994;62:1205–10.PubMedGoogle Scholar
  53. 53.
    Amer A, Hammadeh ME, Kolkailah M, Ghandour AA. Three-dimensional versus two-dimensional ultrasound measurement of follicular volume: are they comparable? Arch Gynecol Obstet. 2003;268:155–7.PubMedGoogle Scholar
  54. 54.
    Penzias AS, Emmi AM, Dubey AK, Layman LC, DeCherney AH, Reindollar RH. Ultrasound prediction of follicle volume: is the mean diameter reflective? Fertil Steril. 1994;62:1274–6.PubMedGoogle Scholar
  55. 55.
    Ata B, Tulandi T. Ultrasound automated volume calculation in reproduction and in pregnancy. Fertil Steril. 2011;95:2163–70.PubMedGoogle Scholar
  56. 56.
    Jayaprakasan K, Hilwah N, Kendall NR, Hopkisson JF, Campbell BK, Johnson IR, Raine-Fenning NJ. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum Reprod. 2007;22:1932–41.PubMedGoogle Scholar
  57. 57.
    Deb S, Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ. Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC. Ultrasound Obstet Gynecol. 2009;33:477–83.PubMedGoogle Scholar
  58. 58.
    Van Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropin infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of PCOS. Fertil Steril. 1997;67:452–8.PubMedGoogle Scholar
  59. 59.
    Pache TD, Hop WC, Wladimiroff JW, Schipper J, Fauser BC. How to discriminate between normal and polycystic ovaries. Radiology. 1992;17:589–93.Google Scholar
  60. 60.
    Erdem A, Erdem M, Biberoglu K, Hayit O, Arslan M, Gursoy R. Age-related changes in ovarian volume, antral follicle counts and basal FSH in women with normal reproductive health. J Reprod Med. 2002;47:835–9.PubMedGoogle Scholar
  61. 61.
    Alsamarai S, Adams JM, Murphy MK, Post MD, Hayden DL, Hall JE, Welt CK. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age. J Clin Endocrinol Metab. 2009;94:4961–70.PubMedGoogle Scholar
  62. 62.
    Kyei-Mensah A, Tan SL, Zaidi J, Jacobs HS. Relationship of ovarian stromal volume to serum androgen concentrations in patients with polycystic ovary syndrome. Hum Reprod. 1998;13:1437–41.PubMedGoogle Scholar
  63. 63.
    Haadsma ML, Bukman A, Groen H, Roeloffzen EM, Groenewoud ER, Heineman MJ, et al. The number of small antral follicles (2-6mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population. Hum Reprod. 2007;22:1925–31.PubMedGoogle Scholar
  64. 64.
    Allemand MC, Tummon IS, Phy JL, Foong SC, Dumesic DA, Session DR. Diagnosis of polycystic ovaries by three-dimensional transvaginal ultrasound. Fertil Steril. 2006;85:214–9.PubMedGoogle Scholar
  65. 65.
    Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau-Jonard S. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod. 2011;26:3123–9.PubMedGoogle Scholar
  66. 66.
    Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ. Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow. Ultrasound Obstet Gynecol. 2008;31:439–44.PubMedGoogle Scholar
  67. 67.
    Raine-Fenning NJ, Campbell BK, Clewes JS, Johnson IR. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. Ultrasound Med Biol. 2003;29:1685–90.PubMedGoogle Scholar
  68. 68.
    Kyei-Mensah A, Maconochie N, Zaidi J, Pittrof R, Campbell S, Tan SL. Transvaginal three-dimensional ultrasound: accuracy of ovarian follicular volume measurements. Fertil Steril. 1996;65:371–6.PubMedGoogle Scholar
  69. 69.
    Ng EH, Chan CC, Yeung WS, Ho PC. Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome. Hum Reprod. 2005;20:1881–6.PubMedGoogle Scholar
  70. 70.
    Pan HA, Wu MH, Cheng YC, Li CH, Chang FM. Quantification of Doppler signal in polycystic ovarian syndrome using 3D power Doppler ultrasonography. Hum Reprod. 2002;17:2484–8.PubMedGoogle Scholar
  71. 71.
    Lam PM, Raine-Fenning NJ. The role of three-dimensional ultrasonography in polycystic ovary syndrome. Hum Reprod. 2006;21:2209–15.PubMedGoogle Scholar
  72. 72.
    Raine-Fenning NJ, Clewes JS, Kendall NR, Bunkheila AK, Campbell BK, Johnson IR. The interobserver reliability and validity of volume calculation from three-dimensional ultrasound datasets in the in vitro setting. Ultrasound Obstet Gynecol. 2003;21:283–91.PubMedGoogle Scholar
  73. 73.
    Lam PM, Johnson IR, Raine-Fenning NJ. Three-dimensional ultrasound features of the polycystic ovary and the effect of different phenotypic expressions on these parameters. Hum Reprod. 2007;22:3116–23.PubMedGoogle Scholar
  74. 74.
    Dewailly D, Robert Y, Helin I, Ardaens Y, Thomas-Desrousseaux P, Lemaitre L, Fossati P. Ovarian stromal hypertrophy in hyperandrogenic women. Clin Endocrinol (Oxf). 1994;41:557–62.Google Scholar
  75. 75.
    Buckett WM, Bouzayen R, Watkin KL, Tulandi T, Tan SL. Ovarian stromal echogenicity in women with normal and polycystic ovaries. Hum Reprod. 1999;14:618–21.PubMedGoogle Scholar
  76. 76.
    Yoo RY, Sirlin CB, Gottschalk M, Chang RJ. Ovarian imaging by magnetic resonance in obese adolescent girls with polycystic ovary syndrome: a pilot study. Fertil Steril. 2005;84:985–95.PubMedGoogle Scholar
  77. 77.
    Lam P, Raine-Fenning NJ, Cheung L, Haines C. Three-dimensional ultrasound features of the polycystic ovary in Chinese women. Ultrasound Obstet Gynecol. 2009;34:196–200.PubMedGoogle Scholar
  78. 78.
    Fulghesu AM, Ciampelli M, Belosi C, Apa R, Pavone V, Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil Steril. 2001;76:326–31.PubMedGoogle Scholar
  79. 79.
    Pache TD, de Jong FH, Hop WC, Fauser BCJM. Association between ovarian changes assessed by transvaginal sonography and clinical and endocrine signs of the polycystic ovary syndrome. Fertil Steril. 1993;59:544–9.PubMedGoogle Scholar
  80. 80.
    Lam PM, Raine-Fenning N. Polycystic ovarian syndrome: a misnomer for an enigmatic disease. Ultrasound Obstet Gynecol. 2009;33:621–7.PubMedGoogle Scholar
  81. 81.
    Fulghesu A, Angioni S, Frau E, Belosi C, Apa R, Mioni R, Xamin N, Capobianco GP, Dessole S, Fruzzetti F, Lazzarini V, Minerba L, Melis GB, Lanzone A. Ultrasound in polycystic ovary syndrome-the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Hum Reprod. 2007;22:2501–8.PubMedGoogle Scholar
  82. 82.
    Belosi C, Selvaggi L, Apa R, Guido M, Romualdi D, Fulghesu AM, Lanzone A. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod. 2006;21:3108–15.PubMedGoogle Scholar
  83. 83.
    Ardaens Y, Robert Y, Lemaitre L, Fossati P, Dewailly D. Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil Steril. 1991;55:1062–8.PubMedGoogle Scholar
  84. 84.
    Pache TD, Hop WC, Wladimiroff JW, Schipper J, Fauser BCJM. Transvaginal sonography and abnormal ovarian appearance in menstrual cycle disturbances. Ultrasound Med Biol. 1991;17:589–93.PubMedGoogle Scholar
  85. 85.
    Al-Took S, Watkin K, Tulandi T, Tan SL. Ovarian stromal echogenicity in women with clomiphene citrate-sensitive and clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 1999;71:952–4.PubMedGoogle Scholar
  86. 86.
    Jarvela IY, Mason HD, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G. Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography. J Assist Reprod Genet. 2002;19:582–90.PubMedGoogle Scholar
  87. 87.
    Pascual MA, Graupera B, Hereter L, Tresserra F, Rodriguez I, Alcazar JL. Assessment of ovarian vascularization in the polycystic ovary by three-dimensional power Doppler ultrasonography. Gynecol Endocrinol. 2008;24:631–6.PubMedGoogle Scholar
  88. 88.
    Agrawal R, Sladkevicius P, Engmann L, Conway GS, Payne NN, Bekis J, Tan SL, Campbell S, Jacobs HS. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod. 1998;13:651–5.PubMedGoogle Scholar
  89. 89.
    Deb S, Jayaprakasan K, Campbell BK, Clewes JS, Raine-Fenning NJ. The interovarian variation in three-dimensional ultrasound markers of ovarian reserve in women undergoing baseline investigation for subfertility. Fertil Steril. 2011;95:667–72.PubMedGoogle Scholar
  90. 90.
    Aleem FA, Predanic M. Transvaginal color Doppler determination of the ovarian and uterine blood flow characteristics in polycystic ovary disease. Fertil Steril. 1996;65:510–6.PubMedGoogle Scholar
  91. 91.
    Ozkan S, Vural B, Caliskan E, Bodur H, Turkoz E, Vural F. Color Doppler sonographic analysis of uterine and ovarian artery blood flow in women with polycystic ovary syndrome. J Clin Ultrasound. 2007;35:305–13.PubMedGoogle Scholar
  92. 92.
    Loverro G, Vicino M, Lorusso F, Vimercati A, Greco P, Selvaggi L. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow. Gynecol Endocrinol. 2001;15:142–9.PubMedGoogle Scholar
  93. 93.
    Zaidi J, Campbell S, Pittrof R, Kyei-Mensah A, Shaker A, Jacobs HS, Tan SL. Ovarian stromal blood flow in women with polycystic ovaries-a possible new marker for diagnosis? Hum Reprod. 1995;10:1992–6.PubMedGoogle Scholar
  94. 94.
    Dolz M, Osborne NG, Blanes J, Raga F, Abad-Velasco L, Villalobos A, Pellicer A, Bonilla-Musoles F. Polycystic ovarian syndrome: assessment with color Doppler angiography and three-dimensional ultrasonography. J Ultrasound Med. 1999;18:303–13.PubMedGoogle Scholar
  95. 95.
    Tugrul S, Oral O, Guclu M, Kutlu T, Uslu H, Pekin O. Significance of Doppler ultrasonography in the diagnosis of polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2006;33:154–8.PubMedGoogle Scholar
  96. 96.
    Younis JS, Jadaon JE, Haddad S, Izhaki I, Ben-Ami M. Prospective evaluation of basal stromal Doppler studies in women with good ovarian reserve and infertility undergoing in vitro fertilization-embryo transfer treatment: patients with polycystic ovary syndrome versus ovulatory patients. Fertil Steril. 2011;95:1754–8.PubMedGoogle Scholar
  97. 97.
    Battaglia C, Genazzani AD, Salvatori M, Giulini S, Artini PG, Genazzani AR, Volpe A. Doppler, ultrasonographic and endocrinological environment with regard to the number of small subcapsular follicles in polycystic ovary syndrome. Gynecol Endocrinol. 1999;13:123–9.PubMedGoogle Scholar
  98. 98.
    Pairleitner H, Steiner H, Hasenoehrl G, Staudach A. Three dimensional power Doppler sonography: imaging and quantifying blood flow and vascularization. Ultrasound Obstet Gynecol. 1999;14:139–43.PubMedGoogle Scholar
  99. 99.
    Raine-Fenning NJ, Nordin NM, Ramnarine KV, Campbell BK, Clewes JS, Perkins A, Johnson IR. Determining the relationship between three-dimensional power Doppler data and true blood flow characteristics: an in-vitro flow phantom experiment. Ultrasound Obstet Gynecol. 2008;32:540–50.PubMedGoogle Scholar
  100. 100.
    El Behery MM, Diab AE, Mowafy H, Ebrahiem MA, Shehata AE. Effect of laparoscopic ovarian drilling on vascular endothelial growth factor and ovarian stromal blood flow using 3-dimensional power Doppler. Int J Gynaecol Obstet. 2011;112:119–21.PubMedGoogle Scholar
  101. 101.
    Elmashad AI. Impact of laparoscopic ovarian drilling on anti-Mullerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome. Fertil Steril. 2011;95:2342–6.PubMedGoogle Scholar
  102. 102.
    Mala YM, Ghosh SB, Tripathi R. Three-dimensional power Doppler imaging in the diagnosis of polycystic ovary syndrome. Int J Gynaecol Obstet. 2009;105:36–8.PubMedGoogle Scholar
  103. 103.
    Raine-Fenning NJ, Campbell BK, Clewes JS, Kendall NR, Johnson IR. The interobserver reliability of three-dimensional power Doppler data acquisition within the female pelvis. Ultrasound Obstet Gynecol. 2004;23:501–8.PubMedGoogle Scholar
  104. 104.
    Hann LE, Hall DA, McArdle CR, Seibel M. Polycystic ovarian disease: sonographic spectrum. Radiology. 1984;150:531–4.PubMedGoogle Scholar
  105. 105.
    Orsini LF, Venturoli S, Lorusso R, Pluchinotta V, Paradisi R, Bovicelli L. Ultrasonic findings in polycystic ovarian disease. Fertil Steril. 1985;43:709–14.PubMedGoogle Scholar
  106. 106.
    Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10:2107–11.PubMedGoogle Scholar
  107. 107.
    Shah B, Parnell L, Milla S, Kessler M, David R. Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome. J Pediatr Adolesc Gynecol. 2010;23:146–52.PubMedGoogle Scholar
  108. 108.
    Parisi L, Tramonti M, Casciano S, Zurli A, Gazzarini O. The role of ultrasound in the study of polycystic ovarian disease. J Clin Ultrasound. 1982;10:167–72.PubMedGoogle Scholar
  109. 109.
    Peri N, Levine D. Sonographic evaluation of the endometrium in patients with a history or an appearance of polycystic ovarian syndrome. J Ultrasound Med. 2007;26:55–9.PubMedGoogle Scholar
  110. 110.
    Vanky E, Kjøtrød S, Salvesen KA, Romundstad P, Moen MH, Carlsen SM. Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS. Acta Obstet Gynecol Scand. 2004;83:482–6.PubMedGoogle Scholar
  111. 111.
    Lam P, Johnson I, Raine-Fenning N. Endometrial blood flow is impaired in women with polycystic ovarian syndrome who are clinically hyperandrogenic. Ultrasound Obstet Gynecol. 2009;34:326–34.PubMedGoogle Scholar
  112. 112.
    Ajossa S, Guerriero S, Paoletti AM, Orrù M, Melis GB. The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. Fertil Steril. 2002;77:1136–40.PubMedGoogle Scholar
  113. 113.
    Ajossa S, Guerriero S, Paoletti AM, Orrù M, Melis GB. Hyperinsulinemia and uterine perfusion in patients with polycystic ovary syndrome. Ultrasound Obstet Gynecol. 2002;20:276–80.PubMedGoogle Scholar
  114. 114.
    Chekir C, Nakatsuka M, Kamada Y, Noguchi S, Sasaki A, Hiramatsu Y. Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2005;84:189–95.PubMedGoogle Scholar
  115. 115.
    Battaglia C, Artini PG, Genazzani AD, Sgherzi MR, Salvatori M, Giulini S, Volpe A. Color Doppler analysis in lean and obese women with polycystic ovary syndrome. Ultrasound Obstet Gynecol. 1996;7:342–6.PubMedGoogle Scholar
  116. 116.
    Battaglia C, Artini PG, D’Ambrogio G, Genazzani AD, Genazzani AR. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol. 1995;172:108–13.PubMedGoogle Scholar
  117. 117.
    de Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: physiological effects of estradiol and progesterone. Fertil Steril. 1991;55:775–9.PubMedGoogle Scholar
  118. 118.
    Killam AP, Rosenfeld CR, Battaglia FC, Makowski EL, Meschia G. Effect of estrogens on the uterine blood flow of oophorectomized ewes. Am J Obstet Gynecol. 1973;115:1045–52.PubMedGoogle Scholar
  119. 119.
    Tulandi T, Watkin K, Tan SL. Reproductive performance and three dimensional ultrasound volume determination of polycystic ovaries following laparoscopic ovarian drilling. Int J Fertil Womens Med. 1997;42:436–40.PubMedGoogle Scholar
  120. 120.
    Wu MH, Huang MF, Tsai SJ, Pan HA, Cheng YC, Lin YS. Effects of laparoscopic ovarian drilling on young adult women with polycystic ovarian syndrome. J Am Assoc Gynecol Laparosc. 2004;11:184–90.PubMedGoogle Scholar
  121. 121.
    Engmann L, Sladkevicius P, Agrawal R, Bekir JS, Campbell S, Tan SL. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Fertil Steril. 1999;71:22–9.PubMedGoogle Scholar
  122. 122.
    Cocksedge KA, Li TC, Saravelos SH, Metwally M. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online. 2008;17:151–60.PubMedGoogle Scholar
  123. 123.
    Okon MA, Laird SM, Tuckerman EM, Li TC. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function. Fertil Steril. 1998;69:682–90.PubMedGoogle Scholar
  124. 124.
    Li TC, Spuijbroek MD, Tuckerman E, Anstie B, Loxley M, Laird S. Endocrinological and endometrial factors in recurrent miscarriage. BJOG. 2000;107:1471–9.PubMedGoogle Scholar
  125. 125.
    Cocksedge KA, Saravelos SH, Wang Q, Tuckerman E, Laird SM, Li TC. Does free androgen index predict subsequent pregnancy outcome in women with recurrent miscarriage? Hum Reprod. 2008;23:797–802.PubMedGoogle Scholar
  126. 126.
    Ferreira AM, Pires CR, Moron AF, Araujo Júnior E, Traina E, Mattar R. Doppler assessment of uterine blood flow in recurrent pregnancy loss. Int J Gynaecol Obstet. 2007;98:115–9.PubMedGoogle Scholar
  127. 127.
    Nakatsuka M, Habara T, Noguchi S, Konishi H, Kudo T. Impaired uterine arterial blood flow in pregnant women with recurrent pregnancy loss. J Ultrasound Med. 2003;22:27–31.PubMedGoogle Scholar
  128. 128.
    Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod. 2002;17:190–4.PubMedGoogle Scholar
  129. 129.
    Ng EH, Chan CC, Tang OS, Yeung WS, Ho PC. Endometrial and subendometrial vascularity is higher in pregnant patients with livebirth following ART than in those who suffer a miscarriage. Hum Reprod. 2007;22:1134–41.PubMedGoogle Scholar
  130. 130.
    Mercé LT, Barco MJ, Bau S, Troyano J. Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril. 2008;89:111–7.PubMedGoogle Scholar
  131. 131.
    Zohav E, Orvieto R, Anteby EY, Segal O, Meltcer S, Tur-Kaspa I. Low endometrial volume may predict early pregnancy loss in women undergoing in vitro fertilization. J Assist Reprod Genet. 2007;24:259–61.PubMedGoogle Scholar
  132. 132.
    Mathur R, Kailasam C, Jenkins J. Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil (Camb). 2007;10:75–85.Google Scholar
  133. 133.
    Mathur R, Evbuomwan I, Jenkins J. Prevention and management of ovarian hyperstimulation syndrome. Curr Obstet Gynaecol. 2005;15:132–8.Google Scholar
  134. 134.
    Royal College of Obstetricians and Gynaecologists (RCOG). The management of ovarian hyperstimulation syndrome. RCOG green-top guideline number 5. London: RCOG Press; 2006. p. 1–11.Google Scholar
  135. 135.
    Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8:559–77.PubMedGoogle Scholar
  136. 136.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85:112–20.PubMedGoogle Scholar
  137. 137.
    Papanikolaou EG, Humaidan P, Polyzos NP, Tarlatzis B. Identification of the high-risk patient for ovarian hyperstimulation syndrome. Semin Reprod Med. 2010;28:458–62.PubMedGoogle Scholar
  138. 138.
    Kwee J, Elting ME, Schats R, McDonnell J, Lambalk CB. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization. Reprod Biol Endocrinol. 2007;15:5–9.Google Scholar
  139. 139.
    Agrawal R, Conway G, Sladkevicius P, Tan SL, Engmann L, Payne N, Bekir J, Campbell S, Jacobs H. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil Steril. 1998;70:651–8.PubMedGoogle Scholar
  140. 140.
    Jayaprakasan K, Jayaprakasan R, Al-Hasie HA, Clewes JS, Campbell BK, Johnson IR, Raine-Fenning NJ. Can quantitative three-dimensional power Doppler angiography be used to predict ovarian hyperstimulation syndrome? Ultrasound Obstet Gynecol. 2009;33:583–91.PubMedGoogle Scholar
  141. 141.
    Agrawal R, Conway GS, Sladkevicius P, Payne NN, Bekir J, Campbell S, et al. Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow. Clin Endocrinol (Oxf). 1999;50:101–6.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Third Department of Obstetrics and GynecologyHippokratio General Hospital of Thessaloniki, Greece, Aristotle University of ThessalonikiThessalonikiGreece

Personalised recommendations